TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice

Shaik O. Rahaman, Lisa M. Grove, Sailaja Paruchuri, Brian D. Southern, Susamma Abraham, Kathryn A. Niese, Rachel G. Scheraga, Sudakshina Ghosh, Charles K. Thodeti, David X. Zhang, Magdalene M. Moran, William P. Schilling, Daniel J Tschumperlin, Mitchell A. Olman

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Idiopathic pulmonary fibrosis (IPF) is a fatal fibrotic lung disorder with no effective medical treatments available. The generation of myofibroblasts, which are critical for fibrogenesis, requires both a mechanical signal and activated TGF-β; however, it is not clear how fibroblasts sense and transmit the mechanical signal(s) that promote differentiation into myofibroblasts. As transient receptor potential vanilloid 4 (TRPV4) channels are activated in response to changes in plasma membrane stretch/matrix stiffness, we investigated whether TRPV4 contributes to generation of myofibroblasts and/or experimental lung fibrosis. We determined that TRPV4 activity is upregulated in lung fibroblasts derived from patients with IPF. Moreover, TRPV4-deficient mice were protected from fibrosis. Furthermore, genetic ablation or pharmacological inhibition of TRPV4 function abrogated myofibroblast differentiation, which was restored by TRPV4 reintroduction. TRPV4 channel activity was elevated when cells were plated on matrices of increasing stiffness or on fibrotic lung tissue, and matrix stiffness-dependent myofibroblast differentiation was reduced in response to TRVP4 inhibition. TRPV4 activity modulated TGF-β1-dependent actions in a SMAD-independent manner, enhanced actomyosin remodeling, and increased nuclear translocation of the α-SMA transcription coactivator (MRTF-A). Together, these data indicate that TRPV4 activity mediates pulmonary fibrogenesis and suggest that manipulation of TRPV4 channel activity has potential as a therapeutic approach for fibrotic diseases.

Original languageEnglish (US)
Pages (from-to)5225-5238
Number of pages14
JournalJournal of Clinical Investigation
Volume124
Issue number12
DOIs
StatePublished - Dec 1 2014

Fingerprint

TRPV Cation Channels
Myofibroblasts
Pulmonary Fibrosis
Lung
Idiopathic Pulmonary Fibrosis
Fibrosis
Fibroblasts
Actomyosin
Cell Membrane
Pharmacology

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rahaman, S. O., Grove, L. M., Paruchuri, S., Southern, B. D., Abraham, S., Niese, K. A., ... Olman, M. A. (2014). TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice. Journal of Clinical Investigation, 124(12), 5225-5238. https://doi.org/10.1172/JCI75331

TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice. / Rahaman, Shaik O.; Grove, Lisa M.; Paruchuri, Sailaja; Southern, Brian D.; Abraham, Susamma; Niese, Kathryn A.; Scheraga, Rachel G.; Ghosh, Sudakshina; Thodeti, Charles K.; Zhang, David X.; Moran, Magdalene M.; Schilling, William P.; Tschumperlin, Daniel J; Olman, Mitchell A.

In: Journal of Clinical Investigation, Vol. 124, No. 12, 01.12.2014, p. 5225-5238.

Research output: Contribution to journalArticle

Rahaman, SO, Grove, LM, Paruchuri, S, Southern, BD, Abraham, S, Niese, KA, Scheraga, RG, Ghosh, S, Thodeti, CK, Zhang, DX, Moran, MM, Schilling, WP, Tschumperlin, DJ & Olman, MA 2014, 'TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice', Journal of Clinical Investigation, vol. 124, no. 12, pp. 5225-5238. https://doi.org/10.1172/JCI75331
Rahaman SO, Grove LM, Paruchuri S, Southern BD, Abraham S, Niese KA et al. TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice. Journal of Clinical Investigation. 2014 Dec 1;124(12):5225-5238. https://doi.org/10.1172/JCI75331
Rahaman, Shaik O. ; Grove, Lisa M. ; Paruchuri, Sailaja ; Southern, Brian D. ; Abraham, Susamma ; Niese, Kathryn A. ; Scheraga, Rachel G. ; Ghosh, Sudakshina ; Thodeti, Charles K. ; Zhang, David X. ; Moran, Magdalene M. ; Schilling, William P. ; Tschumperlin, Daniel J ; Olman, Mitchell A. / TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice. In: Journal of Clinical Investigation. 2014 ; Vol. 124, No. 12. pp. 5225-5238.
@article{1b607555ef334d26be5edd4f1235970d,
title = "TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice",
abstract = "Idiopathic pulmonary fibrosis (IPF) is a fatal fibrotic lung disorder with no effective medical treatments available. The generation of myofibroblasts, which are critical for fibrogenesis, requires both a mechanical signal and activated TGF-β; however, it is not clear how fibroblasts sense and transmit the mechanical signal(s) that promote differentiation into myofibroblasts. As transient receptor potential vanilloid 4 (TRPV4) channels are activated in response to changes in plasma membrane stretch/matrix stiffness, we investigated whether TRPV4 contributes to generation of myofibroblasts and/or experimental lung fibrosis. We determined that TRPV4 activity is upregulated in lung fibroblasts derived from patients with IPF. Moreover, TRPV4-deficient mice were protected from fibrosis. Furthermore, genetic ablation or pharmacological inhibition of TRPV4 function abrogated myofibroblast differentiation, which was restored by TRPV4 reintroduction. TRPV4 channel activity was elevated when cells were plated on matrices of increasing stiffness or on fibrotic lung tissue, and matrix stiffness-dependent myofibroblast differentiation was reduced in response to TRVP4 inhibition. TRPV4 activity modulated TGF-β1-dependent actions in a SMAD-independent manner, enhanced actomyosin remodeling, and increased nuclear translocation of the α-SMA transcription coactivator (MRTF-A). Together, these data indicate that TRPV4 activity mediates pulmonary fibrogenesis and suggest that manipulation of TRPV4 channel activity has potential as a therapeutic approach for fibrotic diseases.",
author = "Rahaman, {Shaik O.} and Grove, {Lisa M.} and Sailaja Paruchuri and Southern, {Brian D.} and Susamma Abraham and Niese, {Kathryn A.} and Scheraga, {Rachel G.} and Sudakshina Ghosh and Thodeti, {Charles K.} and Zhang, {David X.} and Moran, {Magdalene M.} and Schilling, {William P.} and Tschumperlin, {Daniel J} and Olman, {Mitchell A.}",
year = "2014",
month = "12",
day = "1",
doi = "10.1172/JCI75331",
language = "English (US)",
volume = "124",
pages = "5225--5238",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "12",

}

TY - JOUR

T1 - TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice

AU - Rahaman, Shaik O.

AU - Grove, Lisa M.

AU - Paruchuri, Sailaja

AU - Southern, Brian D.

AU - Abraham, Susamma

AU - Niese, Kathryn A.

AU - Scheraga, Rachel G.

AU - Ghosh, Sudakshina

AU - Thodeti, Charles K.

AU - Zhang, David X.

AU - Moran, Magdalene M.

AU - Schilling, William P.

AU - Tschumperlin, Daniel J

AU - Olman, Mitchell A.

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Idiopathic pulmonary fibrosis (IPF) is a fatal fibrotic lung disorder with no effective medical treatments available. The generation of myofibroblasts, which are critical for fibrogenesis, requires both a mechanical signal and activated TGF-β; however, it is not clear how fibroblasts sense and transmit the mechanical signal(s) that promote differentiation into myofibroblasts. As transient receptor potential vanilloid 4 (TRPV4) channels are activated in response to changes in plasma membrane stretch/matrix stiffness, we investigated whether TRPV4 contributes to generation of myofibroblasts and/or experimental lung fibrosis. We determined that TRPV4 activity is upregulated in lung fibroblasts derived from patients with IPF. Moreover, TRPV4-deficient mice were protected from fibrosis. Furthermore, genetic ablation or pharmacological inhibition of TRPV4 function abrogated myofibroblast differentiation, which was restored by TRPV4 reintroduction. TRPV4 channel activity was elevated when cells were plated on matrices of increasing stiffness or on fibrotic lung tissue, and matrix stiffness-dependent myofibroblast differentiation was reduced in response to TRVP4 inhibition. TRPV4 activity modulated TGF-β1-dependent actions in a SMAD-independent manner, enhanced actomyosin remodeling, and increased nuclear translocation of the α-SMA transcription coactivator (MRTF-A). Together, these data indicate that TRPV4 activity mediates pulmonary fibrogenesis and suggest that manipulation of TRPV4 channel activity has potential as a therapeutic approach for fibrotic diseases.

AB - Idiopathic pulmonary fibrosis (IPF) is a fatal fibrotic lung disorder with no effective medical treatments available. The generation of myofibroblasts, which are critical for fibrogenesis, requires both a mechanical signal and activated TGF-β; however, it is not clear how fibroblasts sense and transmit the mechanical signal(s) that promote differentiation into myofibroblasts. As transient receptor potential vanilloid 4 (TRPV4) channels are activated in response to changes in plasma membrane stretch/matrix stiffness, we investigated whether TRPV4 contributes to generation of myofibroblasts and/or experimental lung fibrosis. We determined that TRPV4 activity is upregulated in lung fibroblasts derived from patients with IPF. Moreover, TRPV4-deficient mice were protected from fibrosis. Furthermore, genetic ablation or pharmacological inhibition of TRPV4 function abrogated myofibroblast differentiation, which was restored by TRPV4 reintroduction. TRPV4 channel activity was elevated when cells were plated on matrices of increasing stiffness or on fibrotic lung tissue, and matrix stiffness-dependent myofibroblast differentiation was reduced in response to TRVP4 inhibition. TRPV4 activity modulated TGF-β1-dependent actions in a SMAD-independent manner, enhanced actomyosin remodeling, and increased nuclear translocation of the α-SMA transcription coactivator (MRTF-A). Together, these data indicate that TRPV4 activity mediates pulmonary fibrogenesis and suggest that manipulation of TRPV4 channel activity has potential as a therapeutic approach for fibrotic diseases.

UR - http://www.scopus.com/inward/record.url?scp=84915748921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84915748921&partnerID=8YFLogxK

U2 - 10.1172/JCI75331

DO - 10.1172/JCI75331

M3 - Article

C2 - 25365224

AN - SCOPUS:84915748921

VL - 124

SP - 5225

EP - 5238

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 12

ER -